Pre-warning Risk Scoring System for Sudden Cardiac Death
1 other identifier
observational
100,000
1 country
1
Brief Summary
The goal of this observational study is to identify potential indicators for pre-warning of sudden cardiac death (SCD), including clinical biochemistry markers, electrocardiogram, echocardiography, MRI and CT imaging values, genetic markers and so on, and further construct a series of multi-parameter assessments of SCD early screening.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 2, 2023
CompletedFirst Submitted
Initial submission to the registry
May 28, 2024
CompletedFirst Posted
Study publicly available on registry
June 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
June 5, 2024
June 1, 2024
4.8 years
May 28, 2024
June 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sudden cardiac death
Identify participants who die by cardiovascular diseases during follow-up period
Baseline and to the 1-year, 2-year, 5-year follow-up
Secondary Outcomes (4)
All-causes death
Baseline and to the 1-year, 2-year, 5-year follow-up
Recurrence of cardiovascular disease
Baseline and to the 1-year, 2-year, 5-year follow-up
Cardiac arrest
Baseline and to the 1-year, 2-year, 5-year follow-up
Major cardiovascular events
Baseline and to the 1-year, 2-year, 5-year follow-up
Eligibility Criteria
Participants with potential high-risk of sudden cardiac death.
You may qualify if:
- The subjects with the following diagnosis of one or more cardiovascular diseases:
- Coronary heart disease If there is a history of coronary heart disease or a new diagnosis of coronary heart disease, or with a report of coronary angiography that indicates at least one vascular stenosis\>50%. Diagnosis includes chronic coronary syndrome (stable angina, ischemic cardiomyopathy, and occult coronary heart disease) and acute coronary syndrome (unstable angina, ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction).
- Heart failure Individuals with a history of heart failure or newly diagnosed heart failure, including heart failure with reduced ejection fraction (HFrEF, left ventricular ejection fraction (LVEF) ≤40%)、intermediate heart failure (HFmrEF, LVEF 41%-49%,with evidence of spontaneous or excitable increase in left ventricular filling pressure), and ejection fraction preserving heart failure (HFpEF, LVEF≥50%, there is evidence of spontaneous or excitable increase in left ventricular filling pressure).
- Genetically related cardiomyopathy or arrhythmia Cardiomyopathy includes hypertrophic cardiomyopathy (DCM), dilated cardiomyopathy (HCM), arrhythmogenic right ventricular cardiomyopathy (ARVC), inflammatory cardiomyopathy (myocarditis, sarcoidosis, Chagas disease). Hereditary arrhythmias include long QT syndrome, short QT syndrome, Brugada syndrome, idiopathic ventricular fibrillation, catecholamine sensitive polymorphic ventricular tachycardia (CPVT), early repolarization syndrome, etc.
- \) Sign an informed consent form.
You may not qualify if:
- Age\<16 years old;
- Refusal to the follow-up visits;
- Individuals with severe mental disorders who are unable to express their wishes;
- Other obvious physical diseases and abnormal laboratory test results;
- Patients deemed unsuitable for participation in this study by the supervising physician.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Guanzhou, Guangdong, 510120, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jingfeng Wang, M.D.,Ph.D.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 28, 2024
First Posted
June 3, 2024
Study Start
March 2, 2023
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
June 5, 2024
Record last verified: 2024-06